Scrip
Dynavax exercises Symphony option for cash to fund Heplisav
11 November 2009
Sukaina Virji
Please Login to read the full article.
11 November 2009
Sukaina Virji
Dynavax Technologies is exercising its option to purchase Symphony Dynamo (SDI), reaping $20 million in cash and rights to hepatitis C and cancer therapy programmes that were licensed from Dynavax.
SDI was set up in 2006 with
Symphony Capital, a private equity fund, providing $50 million...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
